Trulieve Reports Profitable First Quarter 2026 Results Bolstered by Margins and Cash Flow Generation

First quarter revenue of $287 million, with 59% gross margin Positive net income of $2 million and Adjusted EBITDA of $100 million* Rescheduling of medical marijuana to Schedule III enabled applications for DEA registration  TALLAHASSEE, Fla., May 7, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced its results for the quarter ended March 31, 2026.